The in-vitro activity of trovafloxacin and nine other antimicrobials against 413 anaerobic bacteria

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 2, 1996, Pages 271-281

  Bowker, K E ^a   Wootton, M ^a   Holt, H A ^a   Reeves, D S ^a   MacGowan, A P ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; OFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE; TROVAFLOXACIN;

ANAEROBIC BACTERIUM; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0029760731     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.2.271     Document Type: Article

References (6)

1. Enderman, N. R. & Bremm, K.-D. (1992). Bay y 3118, a novel quinolone: activity against anaerobes. In Program and Abstracts of the Thirty-Second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anheim, California, 1992. Abstract 645, p. 218. American Society for Microbiology, Washington, DC.
2. Goldstein, E. J. C. & Citron, D. M. (1992). Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990 and WIN 57273 against anaerobic bacteria. Antimicrobial Agents and Chemotherapy 36, 1158-62.
3. Murdoch, D. A. & Mitchelmore, I. J. (1991). The laboratory identification for Gram-positive anaerobic cocci. Journal of Medical Microbiology 34, 295-308.
4. Phillips, K. D. (1976). A simple and sensitive technique determining the fermantation reactions of non-sporing anaerobes. Journal of Applied Bacteriology 41, 325-8.
5. Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. (1994). Activity of CP 99,219 compared to that of ciprofloxacin, OPC 17116, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against 489 anaerobes. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 1994. Abstract F20, p. 54. American Society for Microbiology, Washington, DC.
6. Wexler, H. M., Militons, E., Reeves, D. & Finegold, S. M. (1994). In vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria. Journal of Antimicrobial Chemotherapy 34, 579-84.